Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 43Rectal Neoplasms 12Colonic Neoplasms 12Neoplasm Metastasis 6Stomach Neoplasms 5Pancreatic Neoplasms 5Gallbladder Neoplasms 3Colorectal Cancer Metastatic 3Cholangiocarcinoma 3Neutropenia 2Neoplasms 2Bile Duct Neoplasms 2Adenocarcinoma 2mCRC 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Recurrence 1Pretreated Metastatic Colorectal Cancer 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Nasopharyngeal Carcinoma 1Microsatellite-stable Colorectal Cancer 1Metastatic Gastric Adenocarcinoma 1High-grade Extra Pulmonary Neuroendocrine Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Gastric Cancer Adenocarcinoma Metastatic 1Gastric Adenocarcinoma 1

Interventions

Cisplatin 104Radiotherapy, Intensity-Modulated 59Gemcitabine 53toripalimab 35Fluorouracil 30Docetaxel 30Capecitabine 28Radiotherapy 23Drug Therapy 20camrelizumab 19nimotuzumab 16nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11spartalizumab 10endostar protein 8Paclitaxel 8Cetuximab 8tislelizumab 7pembrolizumab 7Endostatins 7Bevacizumab 7anlotinib 6Radiation 6Endoscopy 6fludarabine 5S 1 (combination) 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Carcinoma × trifluridine tipiracil drug combination × Clear all
NCT04627961 2020-11-13

A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal Carcinoma

National University Hospital, Singapore

Phase 2 Unknown
33 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡